Adicet Bio, Inc.

NASDAQ:ACET

Biotechnology

Healthcare
$5.53 +0.25%

+$0.02 today

Market cap
$51.70M
Beta
1.57
P/E (TTM)
-0.8
EPS (TTM)
-$10.13
52W Low $6.01High $17.44

Volume 0.15M

Average 0.12M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$122.11M

FY 2025 · Annual

Net Income

-$116.80M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.73M24.99M000
Cost of Revenue00006.38M
Gross Profit9.73M24.99M00(6.38M)
Gross Margin100.0%100.0%———
Research & Development48.94M71.25M106.04M99.32M99.13M
Selling, General & Admin22.22M26.3M26.53M28.29M22.99M
Operating Expenses71.16M97.54M152.04M127.62M115.73M
Depreciation & Amortization1.54M5.01M6.1M6.47M6.38M
EBITDA(60.41M)(64.7M)(136.54M)(110.65M)(110.39M)
EBITDA Margin-620.9%-258.9%———
Operating Income(61.43M)(72.55M)(152.04M)(127.62M)(122.11M)
Operating Margin-631.4%-290.3%———
Interest Income91K3.76M9.98M10.71M5.78M
Interest Expense176K80K25K4K36K
Other Income / Expenses(691K)2.76M9.38M10.49M5.31M
Income Before Tax(62.12M)(69.79M)(142.66M)(117.12M)(116.8M)
Pre-Tax Margin-638.5%-279.3%———
Income Tax Expense(125K)0000
Net Income(62M)(69.79M)(142.66M)(117.12M)(116.8M)
Net Margin-637.2%-279.3%———
EPS (Basic)(32.00)(27.20)(52.96)(21.28)(16.95)
EPS (Diluted)(32.00)(27.20)(52.96)(21.28)(16.95)
Weighted Avg Shares1.93M2.57M2.69M5.49M6.89M
Weighted Avg Shares (Diluted)1.93M2.57M2.69M5.49M6.89M

ACET Earnings Waterfall · TTM

NASDAQ:ACET · Revenue to Net Income

Key Ratios

EPS$-14.90
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.6
P/S Ratio0.0

Analysis

$0 of revenue converted into -$108.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-14.90, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 8, 2026
8-KCurrent reportSep 1, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
4Statement of changes in beneficial ownershipAug 7, 2026
10-QQuarterly reportAug 5, 2026

How much revenue does ACET generate?

Adicet Bio, Inc. (ACET) reported $0.00 of revenue in fiscal 2025.

Is ACET profitable?

Adicet Bio, Inc. (ACET) reported -$116.80M of net income.